Scholars Central

Case reportPublished 2013

The Risk of Breast Carcinoma with Interferon Plus Ribavarin Therapy during Treatment of Chronic Hepatitis C Virus Infection-A Case Report

Authors: Manuela Stoicescu

Journal of Developing Drugs

Volume 2 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The risk of therapy with interferon and Ribavarin has been reported, such as: dominated by fatigue, influenza-like symptoms, hematologic abnormalities, and neuropsychiatric symptoms [1,2], but the risk of breast carcinoma of therapy with interferon and Ribavarin has not been seen.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Manuela Stoicescu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels